Suchergebnisse - "Shankaran, Veena"

PubPharm (5)

1

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas

enthalten in: The oncologist | 2022

von Diehl, A. | Hannan, L. | Zhen, D. | +17

2

Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma : A Phase II Study with Long-Term Follow-Up

enthalten in: The oncologist | 2019

von Rosenberg, A. | Rademaker, A. | Hochster, H. | +7

3

Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma : A Phase II Study with Long‐Term Follow‐Up

enthalten in: The oncologist | 2019

von Rosenberg, A. | Rademaker, A. | Hochster, H. | +7

4

Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer

enthalten in: The oncologist | 2014

von Shankaran, V. | Mummy, D. | Koepl, L. | +6

5

Predicting response to EGFR inhibitors in metastatic colorectal cancer : current practice and future directions

enthalten in: The oncologist | 2010

von Shankaran, V. | Obel, J. | Benson, A.

1
[1]